AI-CVD vs ZEUS System (Zio Watch)
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary goal is to leverage existing CT scans for opportunistic, comprehensive cardiovascular and multisystem disease screening without requiring additional patient visits or imaging. This tool is ideal for identifying hidden risks like coronary artery calcium, aortic calcification, and abnormal cardiac chamber volumes from scans already performed for other indications, enabling early intervention.
View AI-CVD →Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if you need long-term, continuous cardiac monitoring to detect and characterize intermittent arrhythmias, especially Atrial Fibrillation. This wearable solution is best suited for patients experiencing symptoms suggestive of arrhythmias or those at risk, where extended, real-time data collection is crucial for diagnosis and management.
View ZEUS System (Zio Watch) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | ZEUS System (Zio Watch) |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Unknown | Cloud-based system with a wearable device |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-CVDAI-CVD integrates seamlessly into existing CT scan workflows, requiring no additional patient interaction or changes to imaging protocols, which minimizes workflow disruption for clinicians and patients. ZEUS System, while designed with patient experience in mind, requires active patient engagement with a wearable device and associated apps, which can introduce compliance challenges.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value in distinct areas of cardiology. AI-CVD provides broad, opportunistic screening for multiple cardiovascular risk factors from existing CT scans, enabling early detection of hidden health risks. ZEUS System offers highly accurate, long-term continuous monitoring for specific cardiac arrhythmias like AFib, providing crucial data for diagnosis and management.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, making a direct comparison of their cost-effectiveness impossible. While ZEUS System is described as a 'cost-effective' solution, specific pricing details are not publicly available for either product.
Enterprise Readiness
ZEUS System (Zio Watch)ZEUS System explicitly states HIPAA compliance and BAA availability, and search results confirm robust EHR integration capabilities, particularly with Epic via Aura, which streamlines clinical workflows for enterprises. While AI-CVD integrates with existing CT infrastructure, its compliance details are less transparent ('likely, contact vendor'), and specific enterprise integration features are not as clearly articulated.
Innovation
ZEUS System (Zio Watch)ZEUS System demonstrates a higher degree of innovation by combining a novel wearable biosensor for continuous ECG and PPG data collection with an AI-powered algorithm for long-term arrhythmia detection and characterization, representing a disruptive new monitoring platform. AI-CVD is innovative in its opportunistic screening from existing CT scans, but ZEUS System's multi-modal, continuous data acquisition via a wearable for extended periods pushes the boundaries of cardiac monitoring.
Support & Docs
ZEUS System (Zio Watch)ZEUS System provides comprehensive support and documentation, including dedicated customer support, a specialized billing team, and extensive instructions for use in multiple languages. Its integrated ZioSuite portal and MyZio patient app also offer digital tools for patient management, education, and report interpretation, which are not explicitly detailed for AI-CVD.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | ZEUS System (Zio Watch) |
|---|---|---|
| Name | AI-CVD | ZEUS System (Zio Watch) |
| Company | HeartLung Corporation | iRhythm Technologies |
| Primary Function/Use Case | Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Long-term continuous cardiac monitoring for detection and characterization of Atrial Fibrillation (AFib) and other cardiac arrhythmias. |
| Data Source | Existing chest and abdominal CT scans | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection |
| Key Detections/Measurements | Coronary Artery Calcium (CAC) scoring, Aortic wall/valve/mitral valve calcium analysis, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing. | Atrial Fibrillation (AFib) burden, other cardiac arrhythmias. |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and ZEUS System (Zio Watch).
Frequently Asked Questions
More Comparisons
More matchups featuring AI-CVD or ZEUS System (Zio Watch)
Backers
Who funded each tool's parent company.